Peptides are high biological response medicines mainly used for anti-diabetic, anti-cancer and used in many health diseases.

Peptides, short chains of amino acids, have shown great potential in targeting specific biological processes within the body. Their ability to mimic natural proteins and influence biological functions makes them a promising avenue for therapeutic development. Peptide-based treatments offer targeted and efficient alternatives to traditional medications, often with fewer side effects.

The global Peptide Therapeutics market is poised for substantial growth, with an estimated value of USD 32.84 billion in 2023, projected to reach USD 76.83 billion by 2032.